The vaccination acceptance, confidence, and conviction on influenza in the Middle East, Eurasia, and Africa among healthcare providers (VACCIMENA-HCP) project 2023: Determinants of vaccination behavior
Mine Durusu Tanriover, Gaelle Vallee-Tourangeau, Valentin A. Kokorin, Vera N. Larina, Mouna Maamar, Hicham Harmouche, Oğuz Abdullah Uyaroğlu, Dilan Yağmur Kutlay, Jalila Ben Khelil, Abdul-Azeez A. Anjorin, Muhammad Suleman Rana, Jabrayil Jabrayilov, Fatima Al Slail

TL;DR
This study examines how healthcare providers in the Middle East, Eurasia, and Africa feel about flu vaccines and how their attitudes affect their own and their patients' vaccination rates.
Contribution
The study identifies distinct clusters of healthcare providers based on their vaccination attitudes and shows how these clusters influence vaccination behavior.
Findings
Hesitant healthcare providers had low vaccination and advocacy rates for influenza.
Engaged providers were more likely to vaccinate themselves and advocate for patient vaccination.
Cluster membership strongly predicted vaccination behaviors, with regional differences observed.
Abstract
•Healthcare providers (HCPs) play a crucial role in vaccine acceptance and advocacy.•Barriers and drivers of HCPs vaccine acceptance and advocacy were explored.•Sentiment cluster profiles were “engaged”/“hesitant” and “confident”/“diffident.”•Hesitant HCPs exhibited low rates of influenza vaccination and advocacy.•Engaged HCPs more likely to vaccinate themselves and their patients. Healthcare providers (HCPs) play a crucial role in vaccine acceptance and advocacy. Barriers and drivers of HCPs vaccine acceptance and advocacy were explored. Sentiment cluster profiles were “engaged”/“hesitant” and “confident”/“diffident.” Hesitant HCPs exhibited low rates of influenza vaccination and advocacy. Engaged HCPs more likely to vaccinate themselves and their patients. Annual vaccination is the most effective way to prevent and control the health and economic burden of seasonal influenza.…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsVaccine Coverage and Hesitancy · Influenza Virus Research Studies · COVID-19 epidemiological studies
